Pardee Makes Changes To Eligibility For Infusion
Last updated 10/6/2021 at 3:23pm
In response to diminishing supply and ongoing demand for the highly effective monoclonal antibody treatment, Pardee UNC Health Care announced Wednesday that it is adjusting patient eligibility criteria.
In order to manage supply and continue to serve the community, Pardee will only accept referrals to the clinic for COVID-positive patients who are within 5 days of onset of their symptoms, rather than accepting patients within 10 days of onset of their symptoms.
In addition, Pardee will utilize both REGEN-CoV and bamlanivimab and etesevimab (BAM/ETE) combination monoclonal antibody infus...